Metabolic Changes Associated With Antipsychotic Use

AUTOR(ES)

Lieberman, Joseph A.

FONTE

Physicians Postgraduate Press

RESUMO

In the United States, the risk of type 2 diabetes is currently growing to epidemic proportions, with many physicians unaware that disorders such as schizophrenia and bipolar disorder naturally place patients at an increased risk for diabetes. Another serious concern for physicians is the development of metabolic syndrome, also known as syndrome X, in patients suffering from schizophrenia. Metabolic syndrome often encompasses medical conditions such as weight gain, hypertriglyceridemia, and increased insulin, glucose, and low-density lipoprotein cholesterol levels. Treatment with atypical antipsychotics may increase the risk of metabolic syndrome and diabetes, and physicians need to be proactive when treating patients with schizophrenia. Physicians should be aware that the treatment of schizophrenia involves the right balance for the patient in terms of adverse effects versus benefit, and failing to treat a patient's mental illness because of potential medical problems may place the patient at an increased risk for more serious problems.

Documentos Relacionados

• Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
• Metabolic Changes Associated with Adaptation of Plant Cells to Water Stress 1
• Metabolic changes associated with the germination of corn. II. Nucleic acid metabolism.
• Transient corneal changes associated with the use of gold foil electrodes.
• Female alcoholics: electrocardiographic changes and associated metabolic and electrolytic disorders